Drug Profile
Human papillomavirus vaccine recombinant monovalent - Novavax
Alternative Names: Cervical cancer vaccine - King/Novavax; HPV-16 L1 vaccine - King/Novavax; HPV-16 L1 VLP vaccine - Novavax; HPV-16 vaccine - King/Novavax; Human papillomavirus 16 L1 virus-like particle vaccine - NovavaxLatest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator National Cancer Institute (USA); Novavax
- Class Cancer vaccines; Papillomavirus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Human papillomavirus infections
Most Recent Events
- 06 Sep 2011 Discontinued - Phase-II for Human papillomavirus infections in Costa Rica (IM)
- 06 Sep 2011 Discontinued - Phase-II for Human papillomavirus infections in USA (IM)
- 03 May 2001 Phase-II clinical trials for Human papillomavirus infections in Costa Rica (IM)